Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Ashok AGARWAL; Neel PAREKH; Manesh-Kumar PANNER-SELVAM; Ralf HENKEL; Rupin SHAH; Sheryl-T HOMA; Ranjith RAMASAMY; Edmund KO; Kelton TREMELLEN; Sandro ESTEVES; Ahmad MAJZOUB; Juan-G ALVAREZ; David-K GARDNER; Channa-N JAYASENA; Jonathan-W RAMSAY; Chak-Lam CHO; Ramadan SALEH; Denny SAKKAS; James-M HOTALING; Scott-D LUNDY; Sarah VIJ; Joel MARMAR; Jaime GOSALVEZ; Edmund SABANEGH; Hyun-Jun PARK; Armand ZINI; Parviz KAVOUSSI; Sava MICIC; Ryan SMITH; Gian-Maria BUSETTO; Mustafa-Emre BAKIRCIOĞLU; Gerhard HAIDL; Giancarlo BALERCIA; Nicolás-Garrido PUCHALT; Moncef BEN-KHALIFA; Nicholas TADROS; Jackson KIRKMAN-BROWNE; Sergey MOSKOVTSEV; Xuefeng HUANG; Edson BORGES; Daniel FRANKEN; Natan BAR-CHAMA; Yoshiharu MORIMOTO; Kazuhisa TOMITA; Vasan-Satya SRINI; Willem OMBELET; Elisabetta BALDI; Monica MURATORI; Yasushi YUMURA; Sandro LA-VIGNERA; Raghavender KOSGI; Marlon-P MARTINEZ; Donald-P EVENSON; Daniel-Suslik ZYLBERSZTEJN; Matheus ROQUE; Marcello COCUZZA; Marcelo VIEIRA; Assaf BEN-MEIR; Raoul ORVIETO; Eliahu LEVITAS; Amir WISER; Mohamed ARAFA; Vineet MALHOTRA; Sijo-Joseph PAREKATTIL; Haitham ELBARDISI; Luiz CARVALHO; Rima DADA; Christophe SIFER; Pankaj TALWAR; Ahmet GUDELOGLU; Ahmed-M-A MAHMOUD; Khaled TERRAS; Chadi YAZBECK; Bojanic NEBOJSA; Damayanthi DURAIRAJANAYAGAM; Ajina MOUNIR; Linda-G KAHN; Saradha BASKARAN; Rishma-Dhillon PAI; Donatella PAOLI; Kristian LEISEGANG; Mohamed-Reza MOEIN; Sonia MALIK; Onder YAMAN; Luna SAMANTA; Fouad BAYANE; Sunil-K JINDAL; Muammer KENDIRCI; Baris ALTAY; Dragoljub PEROVIC; Avi HARLEV.
The World Journal of Men's Health ; : 296-312, 2019.
Artigo em Inglês | WPRIM | ID: wpr-761886

RESUMO

Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm's potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants (antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis, future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause.


Assuntos
Feminino , Humanos , Masculino , Antioxidantes , Classificação , Protocolos Clínicos , Diagnóstico , DNA , Estruturas Embrionárias , Fertilidade , Gastos em Saúde , Infertilidade , Infertilidade Masculina , Membranas , Óvulo , Oxidantes , Oxirredução , Estresse Oxidativo , Espécies Reativas de Oxigênio , Substâncias Redutoras , Saúde Reprodutiva , Sêmen , Espermatozoides , Descritores
2.
Asian Journal of Andrology ; (6): 865-871, 2008.
Artigo em Inglês | WPRIM | ID: wpr-284733

RESUMO

<p><b>AIM</b>To examine the relationship between sperm DNA damage and sperm nuclear histone (H2B) staining.</p><p><b>METHODS</b>We evaluated sperm samples from 14 consecutive asthenoteratozoospermic infertile men and six consecutive fertile controls. Sperm nuclear histone (H2B) staining and sperm chromatin integrity (assessed by sperm chromatin structure assay and expressed using the percentage of (i) DNA fragmentation index [% DFI] and (ii) high DNA stainability [% HDS)]) were evaluated.</p><p><b>RESULTS</b>Histone H2B immunocytochemistry demonstrated two nuclear staining patterns: (i) focal punctate staining; and (ii) diffuse staining. Infertile men had a higher mean percentage of spermatozoa exhibiting diffuse H2B staining than did fertile men (7.7% +/- 4.6% vs. 1.6% +/- 1.2%, respectively, P < 0.01). We observed significant relationships between the proportion of spermatozoa with diffuse nuclear histone staining and both sperm % DFI (r = 0.63, P < 0.01) and sperm %HDS (r = 0.63, P < 0.01).</p><p><b>CONCLUSION</b>The data demonstrate that infertile men have a higher proportion of spermatozoa with diffuse histone H2B than do fertile men and suggest that sperm DNA damage might, at least in part, be due to abnormally high histone H2B levels.</p>


Assuntos
Adulto , Humanos , Masculino , Cromatina , Química , Metabolismo , DNA , Fragmentação do DNA , Histonas , Metabolismo , Imuno-Histoquímica , Infertilidade Masculina , Metabolismo , Desnaturação de Ácido Nucleico , Motilidade dos Espermatozoides , Fisiologia , Espermatozoides , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA